Inflammation and Atherosclerosis The End of a Controversy

被引：139

作者：

Hansson, Goran K. ^{[1
,2
]}

机构：

[1] Dept Med, Solna, Sweden

[2] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, L8-03, Stockholm, Sweden

来源：

CIRCULATION | 2017年 / 136卷 / 20期

关键词：

atherosclerosis; atherothrombosis; clinical trial; inflammation; interleukin-1; myocardial infarction;

D O I：

10.1161/CIRCULATIONAHA.117.030484

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：1875 / 1877

页数：3

共 5 条

[1]

Anti-inflammatory therapies for atherosclerosis [J].

Back, Magnus ;

Hansson, Goran K. .

NATURE REVIEWS CARDIOLOGY, 2015, 12 (04) :199-211

[2]

Progress and challenges in translating the biology of atherosclerosis [J].

Libby, Peter ;

Ridker, Paul M. ;

Hansson, Goran K. .

NATURE, 2011, 473 (7347) :317-325

[3]

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease [J].

Ridker, P. M. ;

Everett, B. M. ;

Thuren, T. ;

MacFadyen, J. G. ;

Chang, W. H. ;

Ballantyne, C. ;

Fonseca, F. ;

Nicolau, J. ;

Koenig, W. ;

Anker, S. D. ;

Kastelein, J. J. P. ;

Cornel, J. H. ;

Pais, P. ;

Pella, D. ;

Genest, J. ;

Cifkova, R. ;

Lorenzatti, A. ;

Forster, T. ;

Kobalava, Z. ;

Vida-Simiti, L. ;

Flather, M. ;

Shimokawa, H. ;

Ogawa, H. ;

Dellborg, M. ;

Rossi, P. R. F. ;

Troquay, R. P. T. ;

Libby, P. ;

Glynn, R. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (12) :1119-1131

[4]

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial [J].

Ridker, Paul M. ;

MacFadyen, Jean G. ;

Thuren, Tom ;

Everett, Brendan M. ;

Libby, Peter ;

Glynn, Robert J. .

LANCET, 2017, 390 (10105) :1833-1842

[5]

Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]

← 1 →